In conclusion, we identified an S A67V cytotoxic lymphocyte (CTL) epitope suitable for evaluating the CD8 T-cell-mediated cellular response and potentially for the development of future COVID-19 vaccine candidates to maximize CTL responses against SARS-CoV-2. The gene discussed is CD8A; the disease is COVID-19.